UBS Maintains a 'Sell' on Home Properties (HME); DC / Baltimore Exposure Remains A Concern

February 14, 2012 11:59 AM EST
Get Alerts HME Hot Sheet
Price: $75.24 --0%

Rating Summary:
    6 Buy, 11 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
UBS maintains a 'Sell' on Home Properties (NYSE: HME) price target raised $4 to $57.

UBS analyst says, "Our concerns surrounding the resiliency of HME’s ‘class-B’ renter-by-necessity tenant base remain in-place. While SS revenue guidance of +4.5% for DC / Baltimore is still solid (53% of NOI), we believe the guidance will be difficult to beat and foresee growth slowing heading into 2013. We think shares remain range-bound at best, with the risk/reward skewed modestly to the downside following the recent run as core growth remains the lowest of the peers and Washington DC / Baltimore concerns are likely to persist – if not intensify."

"We are increasing our 2012 FFOPS estimate to $3.90 (from $3.79) primarily driven by lower interest expense and a modest increase to our ‘core’ assumptions with +4.3% SS revenue growth, +3.8% expense growth, driving SS NOI up 4.8%." (FY13 raised from $4.08 to $4.15)

For an analyst ratings summary and ratings history on Home Properties click here. For more ratings news on Home Properties click here.

Shares of Home Properties closed at $60.64 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

UBS